The National Pharmaceutical Pricing Authority released revised prices for five hundred forty three anti cancer medicine brands, bringing major relief to patients. Effective from November nine, new MRPs show massive drops, such as RPG Life Sciences dropping from six thousand rupees to seventy three rupees. This move follows earlier trade margin rationalisation aiming to make essential treatments much more affordable across India.
